The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bayer
Growth modulation index (GMI) as a comparative efficacy measure of larotrectinib versus prior systemic treatments for TRK fusion cancer patients.
 
Antoine Italiano
Honoraria - Bayer; Daiichi Sankyo; Epizyme; IPSEN; Lilly; Novartis; Roche
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Immune Design; Lilly; Roche
Research Funding - AstraZeneca/MedImmune; Bayer; Merck Serono; Merck Serono; MSD Oncology; PharmaMar; Roche
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
 
David S. Hong
Stock and Other Ownership Interests - MolecularMatch; Oncorena; Presagia
Consulting or Advisory Role - Alphasights; Axiom Biotechnologies; Bayer; Genentech; Gerson Lehrman Group; GroupH; Guidepoint Global; Infinity Pharmaceuticals; Medscape; Merrimack; Numab; Pfizer; PrimE Oncology; Seagen; Takeda; Trieza Therapeutics; WebMD
Research Funding - Abbvie; Adaptimmune; Aldai Norte; Amgen; AstraZeneca/MedImmune; Bayer; Daiichi Sankyo; Fate Therapeutics; Genentech; Infinity Pharmaceuticals; Kite, a Gilead company; Kura Oncology; MedImmune; Mirati Therapeutics; Molecular Templates; National Cancer Institute; Pfizer; Seagen; Shattuck Labs; TCR2 Therapeutics; TP Therapeutics
Travel, Accommodations, Expenses - AACR; ASCO; Bayer Schering Pharma; Genmab; Society for Immunotherapy of Cancer
 
Andrew Briggs
Consulting or Advisory Role - Bayer
 
Jesus Garcia-Foncillas
Consulting or Advisory Role - Abbott; Amgen; Astellas Pharma; AstraZeneca; Bayer; Biocartis; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Eisai; Foundation Medicine; GlaxoSmithKline; Hospira; Janssen; Lilly; Loxo; Merck Serono; MSD; Novartis; Pfizer; PharmaMar; Regeneron; Roche; Sanofi; SERVIER; Sysmex; Tesaro
 
Ulrik Niels Lassen
Honoraria - Bayer; Pfizer
Consulting or Advisory Role - Bayer; Pfizer
Research Funding - Bristol-Myers Squibb (Inst)
 
Gilles Vassal
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Incyte; Ipsen; Lilly; Merck Serono; Novartis; Roche/Genentech; SERVIER; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Shivaani Kummar
Stock and Other Ownership Interests - Drishti
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Corvus Pharmaceuticals; Genentech; Harbour BioMed; MedTree (I); Mundipharma; Nodus Therapeutics; Seagen; ShangPharma Innovation
Research Funding - ADC Therapeutics (Inst); Advenchen Laboratories (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Dynavax Technologies (Inst); Incyte (Inst); Jounce Therapeutics (Inst); Loxo (Inst); Pfizer (Inst); Plexxikon (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bayer
 
Cornelis M. Van Tilburg
Consulting or Advisory Role - Bayer; Novartis
 
Karen N Keating
Employment - Bayer
 
John A. Reeves
Employment - Bayer
 
Marc Mardoche Fellous
Employment - Bayer
 
Barrett H. Childs
No Relationships to Disclose
 
Theodore Willis Laetsch
Consulting or Advisory Role - Bayer; Lilly; Loxo; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Jubilant Pharmaceuticals (Inst); Lilly (Inst); Loxo (Inst); Novartis (Inst); Novella Clinical (Inst); Pfizer (Inst); SERVIER (Inst)
 
Alexander E. Drilon
Honoraria - Foundation Medicine; Medscape; MORE Health; OncLive; Peerview; PeerVoice; Physicans' Education Resource; Research to Practice; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; BerGenBio; Blueprint Medicines; Exelixis; Genentech/Roche; Helsinn Therapeutics; Hengrui Therapeutics; Ignyta; Lilly; Loxo; MORE Health; Pfizer; Takeda/Millennium; TP Therapeutics; Tyra Biosciences; Verastem; Verastem
Research Funding - Foundation Medicine
Patents, Royalties, Other Intellectual Property - Wolters Kluwer (Royalties for Pocket Oncology)
Other Relationship - GlaxoSmithKline; Merck; Pfizer; PharmaMar; Puma Biotechnology; Taiho Pharmaceutical; Teva